Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Ski-T, Big Booths are quite expensive to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
MI Dendream Member Profile
 
Followed By 32
Posts 933
Boards Moderated 0
Alias Born 10/31/17
160x600 placeholder
CEO Presenting at Emerging Growth Conference Virtually This Week InvestorsHub NewsWire - 5/11/2021 7:00:00 AM
Nightfood, Inc. (OTCQB: NGTF) Joins Pepsico (NYSE: PEP), Unilever (NYSE: UL) and Bayer at Event InvestorsHub NewsWire - 5/5/2021 6:28:08 AM
Nightfood, Inc. (OTCQB: NGTF) in Walmart (NYSE: WMT) Coast to Coast over 1,000 Locations InvestorsHub NewsWire - 4/20/2021 7:09:50 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/31/2021 4:56:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2021 8:32:22 AM
Emerging Growth Conference 2 Announced for March 3, 2021 Niche Companies in Technology, AR, eCommerce, Beverage and more .... InvestorsHub NewsWire - 3/1/2021 6:28:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/26/2021 4:55:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/19/2021 4:07:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/15/2021 7:21:09 AM
The FDA Calendar Review Dates Can Play a Big Role in Timing Your Trades, But Not the Way You May Think InvestorsHub NewsWire - 1/7/2021 8:00:00 AM
Biotech Companies; Recent Milestones and Potential Upside InvestorsHub NewsWire - 12/22/2020 8:05:00 AM
TNS is on the Hunt for the Next OTC Home Run Stock, Feature Report InvestorsHub NewsWire - 11/30/2020 8:20:00 AM
Immune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating Officer InvestorsHub NewsWire - 11/11/2020 9:11:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/10/2020 4:58:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 2:16:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:59:18 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/13/2020 9:31:10 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/15/2020 5:14:31 PM
SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers InvestorsHub NewsWire - 9/14/2020 10:10:04 AM
Traders News Source Identifies Tomorrows NASDAQ's InvestorsHub NewsWire - 9/3/2020 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 3:24:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2020 4:52:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:44:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/7/2020 5:27:35 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/26/2020 5:07:03 PM
MI Dendream   Tuesday, 05/04/21 10:38:40 PM
Re: skitahoe post# 374545
Post # of 377849 
Ski-T, Big Booths are quite expensive to build...ridunculous. You can build a house for cheaper. Maybe not in this market though. It is a racket. Personally, I would have built a 16x16 booth to begin with and run with that for a while, but LP thinks BIG and she prepped for big things early before changing course. It is much cheaper to pay the mark up to the congress than to build and store another booth.

As far as presentation vs poster, that ship has sailed. Posters titles were released with everything else. The good news is that LBAs are presentations and are very well attended.

Which comes back to the drum I just can’t stop beating. I just can’t help myself, what can I say...I have passion. Journal articles are read buy some clinicians and are historical reference for all to see. This is good stuff and eventually a necessary step for a product that you want to promote. But congresses and particularly ASCO, have the interest of many including and especially the lay, financial, and medical press.

I am no trading expert but it appears to me that we do not have enough buy side interest to keep the shorts from their endless games. To me, we need press coverage and we need financial analysts and we need everything else that ASCO offers but a journal cannot. Even among physicians, readership ain’t what it used to be.

I have faith that LP knows what she is doing and even if she does not, I know that LL does. Just look at what she is doing. She is more than just a student of the game, she is a captain.

ASCO...we got this!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences